CELL AND GENE THERAPY INSIGHTS

Manufacturing Quality Control for Plasmid DNA Critical Starting Materials

Manufacturing Quality Control for Plasmid DNA Critical Starting Materials

Andrew Frazer, Lauren R. Salvitti
29 April 2025
Register
Optimizing iPSC therapies: strategies for safe, cost-effective, and scalable manufacturing

Optimizing iPSC therapies: strategies for safe, cost-effective, and scalable manufacturing

K Bruce, K Bharti, I Barbaric et al
23 April 2025
Register
Next-generation sequencing in adventitious agent testing: navigating regulatory acceptance

Next-generation sequencing in adventitious agent testing: navigating regulatory acceptance

Olaf Stamm, Horst Ruppach, Minu Youngkin
15 April 2025
Register
Achieving high-titer rAAV production with significantly reduced encapsidated host cell DNA

Achieving high-titer rAAV production with significantly reduced encapsidated host cell DNA

Ines Goncalves
10 April 2025
Register
Moving AAV gene therapy beyond rare disease to address large patient populations with chronic disease

Moving AAV gene therapy beyond rare disease to address large patient populations with chronic disease

Dan Oliver, Ji Hyun Lee
09 April 2025
Register
Armor CAR T cells with enhanced potency for cancer immunotherapy

Armor CAR T cells with enhanced potency for cancer immunotherapy

Saba Ghassemi
08 April 2025
Register
Achieving rapid microbiological monitoring in fill-finish with biofluorescent particle counters: a collaborative case study

Achieving rapid microbiological monitoring in fill-finish with biofluorescent particle counters: a collaborative case study

M Dingle, A Carwell, M J. Miller et al
08 April 2025
Register
Fit-for-purpose analytical development for an emerging cell therapy landscape

Fit-for-purpose analytical development for an emerging cell therapy landscape

J Wei, D Rill, F Durst et al
03 April 2025
Register
Transforming viral vector manufacturing with next-generation CGMP plasmids platform

Transforming viral vector manufacturing with next-generation CGMP plasmids platform

John Bowen, Brian Tomkowicz
02 April 2025
Register
Cost reduction of viral vector processes using 3D nanofiber-based cell culture systems in upstream bioprocessing

Cost reduction of viral vector processes using 3D nanofiber-based cell culture systems in upstream bioprocessing

Rob Noel, Geddy Hamblen, Christel Fenge
01 April 2025
Register
Strategies for streamlined manufacturing and analytics in CGT development

Strategies for streamlined manufacturing and analytics in CGT development

Laura Mueller, Silvio Weber, Dirk Windgassen
01 April 2025
Register
Producing MSC-derived cell therapies: workflows, technologies, and case studies

Producing MSC-derived cell therapies: workflows, technologies, and case studies

I Malaspina, S Mei, T Ting et al
28 March 2025
Expert Roundtable
Advancing cell therapy: Optimizing the cell culture environment for high-quality manufacture of suspension and adherent cells

Advancing cell therapy: Optimizing the cell culture environment for high-quality manufacture of suspension and adherent cells

Mindy Miller, Nathan Frank
27 March 2025
Watch
Salt-tolerant endonucleases, the benefits for viral vector manufacturing and a comparison of two marketed enzymes

Salt-tolerant endonucleases, the benefits for viral vector manufacturing and a comparison of two marketed enzymes

Marc Struhalla, Svenja Michalek
26 March 2025
Innovator Insight
Efficient AAV purification: resin reuse and scalable polish method

Efficient AAV purification: resin reuse and scalable polish method

Nicolas Laroudie, Duncan Dulac
25 March 2025
Watch
Transforming cell therapy manufacturing: smart automation & genetic modification for scalable success

Transforming cell therapy manufacturing: smart automation & genetic modification for scalable success

Peter Szaraz, Tessel Hammink
20 March 2025
Watch
Ensuring compliance through collaboration: managing raw material changes in cell and gene therapy regulatory filings

Ensuring compliance through collaboration: managing raw material changes in cell and gene therapy regulatory filings

Kasey Kime, Xiao Peng
20 March 2025
Innovator Insight
Industrialization of AAV manufacturing with Xcite® transient and stable production platforms

Industrialization of AAV manufacturing with Xcite® transient and stable production platforms

Suparna Sanyal, Peng Wang
19 March 2025
Watch
Streamlining the supply chain: insights on raw material sourcing and quality by design

Streamlining the supply chain: insights on raw material sourcing and quality by design

Lara Silverman
19 March 2025
Interview
GMP or not? Understanding raw material quality grades and requirements for ATMP manufacturing

GMP or not? Understanding raw material quality grades and requirements for ATMP manufacturing

Lili Belcastro, Basak Clements, Claire Wartel
18 March 2025
Watch
Driving innovation to advance allogeneic cell therapies through manufacturing platform development

Driving innovation to advance allogeneic cell therapies through manufacturing platform development

Jason Dowd
18 March 2025
Interview